Apsara Life Science Consulting, LLC

Offering strategic insight and guidance to inform life science investment, product development, pricing, market access and commercialization strategy for pharmaceuticals and biotechnology assets. Expertise in global P&MA dynamics and strategy, EU commercialization/ go-to-market strategy, asset valuation, portfolio prioritization and evidence generation strategy across a range of therapeutic areas, with a particular focus on orphan drugs Strong network of global payers and P&MA experts that is leveraged to gain relevant insights through advisory boards, workshops and discussion programs